Características clínicas y microbiológicas de pacientes con neutropenia febril en un hospital Universitario

Garzón, Javier Ricardo; Isaza, Nicolas; Posada, Adriana; Mendez, Rafael; Arenas, Juliana; Ardila, Maria Paula; Cardenas, Felipe; Barrera, Viviana; Moreno, Paula; Córdoba, Iris; Rodríguez, Maria Nelcy.
Infectio ; 23(4): 347-351, Dec. 2019. tab, graf
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-1019864

Documentos relacionados

  1. Persister cell plasticity in tumour drug resistance.
  2. Cancer Chemoresistance; Recent Challenges and Future Considerations.
  3. Converting cancer therapies into cures: lessons from infectious diseases.
  4. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future.
  5. Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies.
  6. The tumor organismal environment: Role in tumor development and cancer immunotherapy.
  7. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade.
  8. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
  9. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
  10. Live or Let Die: T Cell Survival in Cancer Immunotherapy.